Physician profile
Barry Saffran
NPI 1215960620
$2,862.82
in general payments reported to CMS, 2019-2025
29 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $760 · 2020: $57.35 · 2021: $222 · 2022: $665 · 2023: $468 · 2024: $543 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $385.12 | 2019-2024 | Kimyrsa |
| Stryker Corporation | $345.11 | 2019-2023 | Prophecy, Variax |
| Horizon Therapeutics Plc | $294.38 | 2019-2023 | Krystexxa |
| Heron Therapeutics, INC. | $151.50 | 2022 | |
| Smith+Nephew, INC. | $141.56 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $134.05 | 2024 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $132.18 | 2022-2023 | Jublia |
| Triad Life Sciences INC. | $131.19 | 2022 | |
| Bioventus LLC | $124.99 | 2022 | |
| Convatec INC. | $124.99 | 2024 | |
| Osiris Therapeutics INC. | $112.93 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $98.55 | 2024-2025 | |
| Orthofix Medical, INC. | $80.31 | 2020-2024 | Physio-Stim, Spinal-Stim |
| Ossio INC | $79.68 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $78.11 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $52.25 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biocomposites INC | $47.95 | 2025 | Stimulan |
| Organogenesis INC. | $47.70 | 2022-2024 | |
| Progenacare Global, LLC | $46.75 | 2024 | |
| Novastep INC. | $43.79 | 2025 | Nexis |
| Wright Medical Technology, INC. | $37.79 | 2020 | |
| Biom'Up Sa | $33.42 | 2019 | |
| Merck Sharp & Dohme LLC | $24.74 | 2019 | |
| Amgen INC. | $24.73 | 2024 | Krystexxa |
| Ani Pharmaceuticals, INC. | $22.65 | 2023 | Purified Cortrophin Gel |
| Nevro Corp. | $19.94 | 2022 | |
| Kci USA, INC. | $19.72 | 2019 | |
| Medtronic, INC. | $14.56 | 2024 | Intellis Adaptivestim |
| Rikco International, LLC | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Saffran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.